The Immune Response To Infection With Treponema Pallidum, The Stealth Pathogen
The Immune Response To Infection With Treponema Pallidum, The Stealth Pathogen
The Immune Response To Infection With Treponema Pallidum, The Stealth Pathogen
www.elsevier.com/locate/micinf
Review
Abstract
Cutaneous immunobiology and spirochetal molecular biology have allowed investigators to propose a conceptual framework for the
development of both the innate and adaptive immune response to Treponema pallidum infection. While some clinical manifestations can
be attributed to humoral responses, most can be attributed to a combination of local innate and adaptive cellular immunity. © 2002 Éditions
scientifiques et médicales Elsevier SAS. All rights reserved.
Keywords: Treponema pallidum; Syphilis; Spirochetes; Innate immunity; Adaptive immunity
failure of adoptively transferred immune reactive serum to that utilized by LPS [37,38]. This ostensible paradox was
completely protect naive rabbits from subsequent intrader- resolved by the discovery that native lipoproteins and
mal challenge with virulent T. pallidum [29]. Moreover, in synthetic analogs signal via toll-like receptor (TLR)2 as
his studies using gamma-irradiated organisms, Miller noted opposed to LPS-mediated signaling which proceeds via
that animals remained fully protected 1 year following the TLR4 [39–41].
completion of immunization in the face of generally low It must be acknowledged that the ultrastructural studies
anti-treponemal antibody titers and, in most cases, nonreac- described earlier raise an obvious paradox: if treponemal
tive T. pallidum-immobilizing antibody tests [27]. The dif- lipoproteins are entirely subsurface, how can they interact
ficulties in resolving these contradictory findings and view- with pattern recognition receptors (PRRs) on the surface of
points are an unfortunate byproduct of the lack of an inbred monocytes/macrophages? Indeed, virulent treponemes are
experimental animal model. extremely poor activators of cultured monocytic cells com-
pared to either T. pallidum lysates or live Borrelia burgdor-
feri, which possesses surface-exposed lipoproteins [42].
5. Tissue-based inflammatory response to T. pallidum: Two potential explanations, which are not mutually exclu-
innate and adaptive immunity sive, can be envisioned. The first is that the innate immune
responses are activated when lipoproteins released from
In recent years, there has been a growing appreciation dead organisms or circulating in the form of immune
that tissue-based inflammation during syphilis is fundamen- complexes bind to PRRs. The second, which we favor, is
tal to both disease progression (i.e., lesion formation) and that lipoproteins gain access to PRRs following degradation
bacterial clearance (i.e., lesion resolution) and that the of treponemes within phagolysosomal vacuoles. Three lines
presence of spirochetes within tissues constitutes the driving of evidence support this idea: (a) lipoproteins retain their
force for the activation of resident immune cells and the biological activities even after extensive proteolytic degra-
recruitment of immune effector cells from peripheral blood. dation [34]; (b) TLR2 molecule lines the phagocytic vacu-
Two developments have markedly enhanced our ability to oles of murine macrophages and is capable of “sampling”
examine these interrelated processes. The first is the discov- vacuolar contents [43]; and (c) treponemes become highly
ery that treponemal lipoproteins are the dominant proin- stimulatory for human monocytes when they are “driven”
flammatory agonists of syphilitic infection. The second is into phagolysosomes following incubation with the opsonic
the recognition that host defenses against bacterial patho- antibodies present in human syphilitic sera (unpublished
gens involve a complex interplay of innate and adaptive observations).
immune responses [30].
5.2. Treponemal lipoproteins elicit a complex cellular
5.1. Treponemal lipoproteins as proinflammatory agonists response in vivo
The notion that T. pallidum lipoproteins are proinflam- Can treponemal lipoproteins elicit an immune response
matory agonists in syphilis arose from the convergence of in vivo and, if so, what is the nature of the response? To
two separate lines of investigation. The first involved efforts address this critical question, we first used the rabbit model
by us and others to clarify the syphilis spirochete’s distinc- to demonstrate that intradermal injection of lipopeptides
tive molecular architecture; as noted already, these studies elicits cellular infiltrates resembling those observed in
led to the discovery that the major membrane immunogens acquired syphilis in humans [44]. A detailed analysis of the
of T. pallidum are lipoproteins [11]. The second was the infiltrating cells was precluded, however, by the paucity of
pioneering studies by Bessler and Jung [31–33] demonstrat- reagents directed against rabbit immune cells and immuno-
ing that murein lipoprotein of Escherichia coli and synthetic modulators. We therefore turned to an in vivo human skin
lipopeptides based upon the molecule’s N terminus have the model in order to characterize further the in vivo biological
capacity to activate monocytes/macrophages and B cells. properties of T. pallidum lipoproteins [45]. In this model,
Knowing that T. pallidum lacks LPS, the Bessler and Jung mild vacuum suction is used to elicit blister formation at the
studies prompted us to investigate whether treponemal dermo-epidermal junction following intradermal injection
lipoproteins possess proinflammatory properties compa- with treponemal lipopeptides (Fig. 4); fluid within the
rable to those of murein lipoprotein. Indeed, using both blisters contains extravasated immune cells which can then
purified treponemal lipoproteins and synthetic lipopeptides, be analyzed by flow cytometry and compared to peripheral
this conjecture was confirmed in a series of in vitro studies blood. Prior to this study there already existed extensive
which also demonstrated that these activities were abso- evidence that the cellular composition of blister fluid
lutely dependent upon the presence of covalently bound accurately reflects the cellular infiltrates within the under-
N-terminal lipids [34–36]. Subsequent analyses revealed lying dermis.
that as with LPS, cellular activation by lipopro- Preliminary studies revealed that lipopeptides derived
teins/lipopeptides was facilitated by CD14 and NF-jB- from the 17- and 47-kDa T. pallidum lipoproteins elicited
dependent, but involved a signaling pathway distinct from dose-dependent gross inflammatory responses which
1138 J.C. Salazar et al. / Microbes and Infection 4 (2002) 1133–1140
peaked approximately 48 h following injection (Fig. 5). tion of the CD4+ cells in secondary lesions are actually
Consistent with previously published in vitro studies, the macrophages and that macrophages, not T cells, are the
corresponding nonlipidated peptides failed to elicit discern- predominant cell type [9]. Analysis of T-cell subsets indi-
ible gross inflammatory responses. Of particular impor- cated that the relative proportion of CD4 and CD8 cells
tance, blister fluids raised over the lipopeptide injection sites shifts from a CD4 predominance in chancres to a CD8
typically contained hundreds of thousands of leukocytes, majority in secondary lesions [9,46]. The presence of
whereas blisters raised over sites injected with peptides cytotoxic T cells in substantial numbers is of interest given
contained only a modicum of cells. Compared with periph- that one does not usually associate this cell type with the
eral blood, lipopeptide blister fluids were highly enriched immune response to an extracellular pathogen. Cells infil-
for monocytes/macrophages, cutaneous lymphocyte antigen trating primary and secondary syphilis lesions contain
(CLA)-positive T cells, and dendritic cells. The enrichment mRNA for the Th1 cytokines, interleukin 2 (IL-2), gamma
for CLA-positive T cells was of particular interest given that interferon (IFN γ), and IL-12 [47]. Increased expression of
cells bearing this skin addressin typically give rise to a Th1 IL-2 and IFN γ mRNAs by infiltrating cells also has been
response. Subsequent unpublished studies have shown that demonstrated in the rabbit model [48]. It is evident that
T cells recruited by treponemal lipopeptides express other these studies have provided only a bare outline of the local
surface markers indicative of a Th1 phenotype. Staining for adaptive response and that much remains to be learned
maturation/differentiation markers (CD83, CD1a), costimu-
latory molecules (CD80/CD86), and chemokine receptors
(CXCR4 and CCR5) revealed that blister fluid dendritic
cells, particularly the monocytoid subpopulation, were
highly activated and far more developmentally advanced
than their peripheral blood counterparts. Taken as a whole,
these studies demonstrated that treponemal lipopeptides
have the capacity to induce an inflammatory milieu remi-
niscent of that found in early syphilis lesions and that, in a
tissue environment, these agonists recruit a cellular infiltrate
with the potential to bridge innate and adaptive immunity.
Investigators have used immunocytochemical techniques Fig. 5. Immunophenotypic characterization of leukocyte populations in
and, more recently, RT-PCR to probe biopsy specimens blister fluids and whole blood. The lipopeptide-induced proinflammatory
from primary and secondary syphilitic lesions for the response (% live cells) in blister fluid (BF-17L and BF-47L) is shown in
components of adaptive immunity. These studies have comparison to the response in peripheral blood (PB). Asterisks indicate
values that are significantly different than the corresponding value in whole
revealed, not surprisingly, that the cellular infiltrates are blood (P < 0.01). Cells in BF and PB were stained with FITC CD14, PE
composed predominantly of lymphocytes and macrophages. CD20, PerCP CD45, and APC CD38 and analyzed by flow cytometric
Interestingly, our studies indicated that a substantial propor- analysis.
J.C. Salazar et al. / Microbes and Infection 4 (2002) 1133–1140 1139
regarding the immunophenotypes and antigenic specificities [3] M.E. St Louis, J.N. Wasserheit, Elimination of syphilis in the United
of the infiltrating T cells. States, Science 281 (5375) (1998) 353–354.
[4] S.A. Lukehart, K.K. Holmes, Syphilis, in: E. Braunwald, K.J. Issel-
bacher, R.G. Petersdorf, J.D. Wilson, J.B. Martin (Eds.), Harrison’s
Principles of Internal Medicine, McGraw Hill Book Company, New
6. A unifying hypothesis York, 1998, pp. 1023–1033.
[5] D.D. Thomas, M. Navab, D.A. Haake, A.M. Fogelman, J.N. Miller,
Based upon the findings discussed above, one can pro- M.A. Lovett, Treponema pallidum invades intercellular junctions of
endothelial cell monolayers, 85, Proc. Natl. Acad. Sci., USA, 1988,
pose a scenario for the ontogeny of cellular immunity to pp. 3608–3612.
T. pallidum that integrates innate and adaptive responses. [6] B.S. Riley, N. Oppenheimer-Marks, E.J. Hansen, J.D. Radolf,
According to this scheme, pre-programmed innate mecha- M.V. Norgard, Virulent Treponema pallidum activates human vas-
nisms are activated by treponemal lipoproteins in all in- cular endothelial cells, J. Infect. Dis. 165 (1992) 484–493.
fected tissues and in all stages of disease; this “lipoprotein [7] E.G. Clark, N. Danbolt, The, Oslo study of the natural course of
untreated syphilis. An epidemiologic investigation based on a
effect” can be invoked to explain the common histopatho-
re-study of the Boeck–Bruusgaard material, Med. Clin. North Am.
logical features of syphilis lesions and the predominance of 48 (1964) 613–623.
macrophages [4]. Superimposed on this proinflammatory [8] S.R. Thomas, S.C. Quinn, The Tuskegee syphilis study, 1932 to
“backdrop” is an increasingly robust adaptive (i.e., 1972: implications for HIV education and AIDS risk education
T. pallidum-specific) response. Early in the development of programs in the black community, Am. J. Public Health 81 (1991)
1498–1505.
a chancre, a primary immune response ensues because the
[9] R.L. McBroom, A.R. Styles, M.J. Chiu, C. Clegg, C.J. Cockerell,
infiltrating memory effector T cells are not sensitized to J.D. Radolf, Secondary syphilis in persons infected with and not
treponemal antigens. As a result, antigen-presenting cells infected with HIV-1: a comparative immunohistological study, Am.
(APCs) attracted to the site of inflammation must traffic to J. Dermatopathol. 21 (1999) 432–441.
draining lymph nodes in order to present treponemal anti- [10] D.L. Cox, P. Chang, A. McDowall, J.D. Radolf, The outer mem-
brane, not a coat of host proteins, limits the antigenicity of virulent
gens to naive T cells. Trafficking of sensitized T cells back
Treponema pallidum, Infect. Immun. 60 (3) (1992) 1076–1083.
to the genital ulcer would be expected to accelerate bacterial [11] J.D. Radolf, Treponema pallidum and the quest for outer membrane
clearance and subsequent healing of the primary lesion. In proteins, Mol. Microbiol. 16 (1995) 1067–1073.
secondary syphilis lesions, the influx of pre-existing [12] J.D. Radolf, Role of outer membrane architecture in immune
T. pallidum-sensitized T cells would foster a response that evasion by Treponema pallidum and Borrelia burgdorferi, Trends
more efficiently contains local infection, most likely in Microbiol. 2 (1994) 307–311.
[13] C.M. Fraser, S.J. Norris, G.M. Weinstock, O. White, G.G. Sutton,
conjunction with opsonizing antibodies. With progressive R. Dodson, et al., Complete genome sequence of Treponema
T-cell sensitization (again, most likely in conjunction with pallidum, the syphilis spirochete, Science 281 (5375) (1998)
the production of opsonizing antibodies), the host immune 375–388.
response gains the upper hand, secondary relapses become [14] A. Centurion-Lara, C. Castro, L. Barrett, C. Cameron, M. Mostowfi,
less frequent, and the patient progresses from early to late W.C. Van Voorhis, et al., Treponema pallidum major sheath protein
homolog Tpr K is a target of opsonic antibody and the protective
latency. An age-related breakdown of a critical surveillance
immune response, J. Exp. Med. 189 (1999) 647–656.
function in a highly sensitized, persistently infected host [15] K.R.O. Hazlett, T.J. Sellati, T.T. Nguyen, D.L. Cox, M.L. Clawson,
would then give rise to recrudescent disease. M.J. Caimano, et al., The TprK protein of Treponema pallidum is
periplasmic and is not a target of opsonic antibody or protective
immunity, J. Exp. Med. 193 (2001) 1015–1026.
[16] A. Pillay, H. Liu, C.Y. Chen, B. Holloway, A.W. Sturm,
Acknowledgements
B. Steiner, et al., Molecular subtyping of Treponema pallidum
subspecies pallidum, Sex Transm. Dis. 25 (1998) 408–414.
This work was supported in part by Public Health Service [17] S.A. Lukehart, Immunology and pathogenesis of syphilis, in:
Grants AI-26756 (to JDR), AI-38894 (to JDR) and AI- T.C. Quinn (Ed.), Advances in Host Defense Mechanisms. Sexually
10573 (to KROH), General Clinical Research Center Transmitted Diseases, Raven Press, New York, 1992, pp. 141–163.
(GCRC) Grant M01RR06192 awarded to the University of [18] J.D. Radolf, N.R. Chamberlain, A. Clausell, M.V. Norgard, Identi-
fication and localization of integral membrane proteins of Tre-
Connecticut Health Center by the National Institutes of ponema pallidum subsp. pallidum by phase partitioning with the
Health, and The Donaghue Medical Research Foundation nonionic detergent Triton X-114, Infect. Immun. 56 (1988) 490–498.
Grant DF 00-014 (to JCS). We are indebted to Ken Bourell [19] N.H. Bishop, J.N. Miller, Humoral immunity in experimental
for his support with graphic design. syphilis. I. The demonstration of resistance conferred by passive
immunization, J. Immunol. 117 (1976) 191–196.
[20] R.A. Nelson Jr, M.M. Mayer, Immobilization of Treponema palli-
dum in vitro by antibody produced in syphilitic infection, J. Exp.
References Med. 89 (1949) 369–383.
[21] N.H. Bishop, J.N. Miller, Humoral immunity in experimental
[1] C.C. Dennie, A History of Syphilis, in: C. Charles (Ed.), Thomas, syphilis. II. The relationship of neutralizing factors in immune sera
Springfield, 1962. to acquired resistance, J. Immunol. 117 (1976) 197–207.
[2] A.E. Singh, B. Romanowski, Syphilis: review with emphasis on [22] S.A. Lukehart, J.N. Miller, Demonstration of the in vitro phagocy-
clinical, epidemiologic, and some biologic features, Clin. Microbiol. tosis of Treponema pallidum by rabbit peritoneal macrophages,
Rev. 12 (2) (1999) 187–209. J. Immunol. 121 (1978) 2014–2024.
1140 J.C. Salazar et al. / Microbes and Infection 4 (2002) 1133–1140
[23] N.S. Hayes, K.E. Muse, A.M. Collier, J.B. Baseman, Parasitism by [37] M.V. Norgard, L.L. Arndt, D.R. Akins, L.L. Curetty, D.A. Harrich,
virulent Treponema pallidum of host cell surfaces, Infect. Immun. 17 J.D. Radolf, Activation of human monocytic cells by Treponema
(1977) 174–186. pallidum and Borrelia burgdorferi lipoproteins and synthetic li-
[24] D.R. Blanco, J.D. Radolf, M.A. Lovett, J.N. Miller, The antigenic popeptides proceeds via a pathway distinct from that of lipopolysac-
interrelationship between the endoflagella of Treponema phagedenis charide but involves the transcriptional activator NF-kappa B,
biotype Reiter and Treponema pallidum, Nichols strain. I. Trepone- Infect. Immun. 64 (9) (1996) 3845–3852.
micidal activity of cross-reactive endoflagellar antibodies against T. [38] T.J. Sellati, D.A. Bouis, R.L. Kitchens, R.P. Darveau, J. Pugin,
pallidum, J. Immunol. 137 (1986) 2973–2979. R.J. Ulevitch, et al., Treponema pallidum and Borrelia burgdorferi
[25] S.A. Lukehart, S.A. Baker-Zander, R.M. Cheri Lloyd, S. Sell, lipoproteins and synthetic lipopeptides activate monocytic cells via
Characterization of lymphocyte responsiveness in early experimen- a CD14-dependent pathway distinct from that utilized by li-
tal syphilis. II. Nature of cellular infiltration and Treponema palli- popolysaccharide, J. Immunol. 160 (1998) 5455–5464.
dum distribution in testicular lesions, J. Immunol. 124 (1980) [39] E. Lien, T.J. Sellati, A. Yoshimura, T.H. Flo, G. Rawadi, R.W. Fin-
461–467. berg, et al., Toll-like receptor 2 functions as a pattern recognition
[26] H.J. Magnuson, E.W. Thomas, S. Olansky, B.I. Kaplan, L. de Mello, receptor for diverse bacterial products, J. Biol. Chem. 274 (47)
J.C. Cutler, Inoculation syphilis in human volunteers, Medicine 35 (1999) 33419–33425.
(1956) 33–82.
[40] H.D. Brightbill, D.H. Libraty, S.R. Krutzik, R.B. Yang, J.T. Belisle,
[27] J.N. Miller, Immunity in experimental syphilis VI. Successful
J.R. Bleharski, et al., Host defense mechanisms triggered by
vaccination of rabbits with Treponema pallidum, Nichols strain,
microbial lipoproteins through toll-like receptors, Science 285
attenuated by gamma-irradiation, J. Immunol. 110 (1973)
(1999) 732–736.
1206–1215.
[28] P.A. Hanff, T.E. Fehniger, J.N. Miller, M.A. Lovett, Humoral [41] A. Poltorak, X. He, I. Smirnova, M.Y. Liu, C. Van Huffel,
immune response in human syphilis to polypeptides of Treponema X. Du, et al., Defective LPS signaling in C3H/HeJ and
pallidum, J. Immunol. 129 (1982) 1287–1291. C57Bl/10ScCr mice: mutations in Tlr4 gene, Science 282 (1998)
[29] N.H. Bishop, J.N. Miller, Humoral immune mechanisms in experi- 2085–2088.
mental syphilis, in: R.F. Schell, D.M. Musher (Eds.), Pathogenesis [42] T.J. Sellati, D.A. Bouis, M.J. Caimano, A.J. Feulner, C. Ayers,
and Immunology of Treponemal Infection, Marcel Dekker, New E. Lien, et al., Activation of human monocytic cells by Borrelia
York, 1983, pp. 241–270. burgdorferi and Treponema pallidum is facilitated by CD14 and
[30] D.T. Fearon, R.M. Locksley, The instructive role of innate immunity correlates with surface exposure of spirochetal lipoproteins, J. Im-
in the acquired immune response, Science 272 (1996) 50–53. munol. 163 (1999) 2049–2056.
[31] W.G. Bessler, M. Cox, A. Lex, B. Suhr, K.H. Wiesmuller, G. Jung, [43] D.M. Underhill, A. Ozinsky, A.M. Hajjar, A. Stevens, C.B. Wilson,
Synthetic lipopeptide analogs of bacterial lipoprotein are potent M. Bassetti, et al., The Toll-like receptor 2 is recruited to macroph-
polyclonal activators for murine B lymphocytes, J. Immunol. 135 age phagosomes and discriminates between pathogens, Nature 401
(1985) 1900–1905. (6755) (1999) 811–815.
[32] S. Hauschildt, P. Hoffmann, H.U. Beuscher, G. Dufhues, P. Heinrich, [44] M.V. Norgard, B.S. Riley, J.A. Richardson, J.D. Radolf, Dermal
K.H. Wiesmuller, et al., Activation of bone marrow-derived mouse inflammation elicited by synthetic analogs of Treponema pallidum
macrophages by bacterial lipopeptide: cytokine production, phago- and Borrelia burgdorferi lipoproteins, Infect. Immun. 63 (1995)
cytosis, and Ia expression, Eur. J. Immunol. 20 (1990) 63–68. 1507–1515.
[33] P. Hoffmann, S. Heinle, U.F. Schade, H. Loppnow, A.J. Ulmer,
[45] T.J. Sellati, S.L. Waldrop, J.C. Salazar, P.R. Bergstresser, L.J. Picker,
H.D. Flad, et al., Stimulation of human and murine adherent cells by
J.D. Radolf, The cutaneous response in humans to Treponema
bacterial lipoprotein and synthetic lipopeptide analogs, Immunobi-
pallidum lipoproteins involves cellular elements of both innate and
ology 177 (1988) 158–170.
adaptive immunity, J. Immunol. 166 (2001) 4131–4140.
[34] J.D. Radolf, M.V. Norgard, M.E. Brandt, R.D. Isaacs, P.A. Thomp-
son, B. Beutler, Lipoproteins of Borrelia burgdorferi and Treponema [46] A. Tosca, J. Lehou, M. Hatjivasiliou, A. Varelzidis, J.D. Stratigos,
pallidum activate cachectin/tumor necrosis factor synthesis: analysis Infiltrate of syphilitic lesions before and after treatment, Genitourin.
using a CAT reporter construct, J. Immunol. 147 (1991) 1968–1974. Med. 64 (1988) 289–293.
[35] D.R. Akins, B.K. Purcell, M. Mitra, M.V. Norgard, J.D. Radolf, [47] W.C. Van Voorhis, L.K. Barrett, D.M. Koelle, J.M. Nasio,
Lipid modification of the 17-kilodalton membrane immunogen of F.A. Plummer, S.A. Lukehart, Primary and secondary syphilis
Treponema pallidum determines macrophage activation as well as lesions contain mRNA for Th1 cytokines, J. Infect. Dis. 173 (1996)
amphiphilicity, Infect. Immun. 61 (1993) 1202–1210. 491–495.
[36] J.D. Radolf, L.L. Arndt, D.R. Akins, L.L. Curetty, M.E. Levi, [48] T.W. Arroll, A. Centurion-Lara, S.A. Lukehart, W.C. Van Voorhis,
Y. Shen, et al., Treponema pallidum and Borrelia burgdorferi T-Cell responses to Treponema pallidum subsp. pallidum antigens
lipoproteins and synthetic lipopeptides activate during the course of experimental syphilis infection, Infect. Immun.
monocytes/macrophages, J. Immunol. 154 (1995) 2866–2877. 67 (1999) 4757–4763.